본문 바로가기

Journals

  • Home
  • Cyber Information Center
  • Journals
Journals
Journal Corresponding Author Writer,Title,Journal,Publication;Year;Page:Volume(Impact Factor)
First Author
Survival of lung cancer patients according to screening eligibility using Korean Lung Cancer Registry 2014-2016 Cha Hyo Soung
(Data Planning & Technology Team)

Lee Sang Won
(Data Curation & Construction Team)
. Survival of lung cancer patients according to screening eligibility using Korean Lung Cancer Registry 2014-2016. SCIENTIFIC REPORTS. 2024-09-29; 2024; 14:22585~. IF 3.8 (2023)
Cost-effectiveness of next-generation sequencing for advanced EGFR/ALK-negative non-small cell lung cancer Kang Sokbom
(Division of Clinical Research)


()
. Cost-effectiveness of next-generation sequencing for advanced EGFR/ALK-negative non-small cell lung cancer. LUNG CANCER. 2024-09-28; 2024; 197:107970~. IF 4.5 (2023)
Prevalence Estimation of the PALB2 Germline Variant in East Asians and Koreans through Population Database Analysis Sun-Young Kong
(Targeted Therapy Branch)


()
. Prevalence Estimation of the PALB2 Germline Variant in East Asians and Koreans through Population Database Analysis. CANCERS. 2024-09-28; 2024; 16(19):3318~. IF 4.5 (2023)
Use of Antiperspirant Products and Risk of Breast Cancer: A Meta-Analysis of Case-Control Studies Myung, Seung-Kwon
(Department of Cancer AI and Digital Health)

Thao Thi Kim TRINH
(Department of Cancer Control and Population Health)
. Use of Antiperspirant Products and Risk of Breast Cancer: A Meta-Analysis of Case-Control Studies. CANCER INVESTIGATION. 2024-09-26; 2024; 42(9):782~792. IF 1.8 (2023)
Reply to Letter regarding Cho Yu Ri
(Targeted Therapy Branch)

Cho Yu Ri
(Targeted Therapy Branch)
. Reply to Letter regarding "Bariatric intervention improves metabolic dysfunction-associated steatohepatitis in patients with obesity: A systematic review and meta-analysis". CLINICAL AND MOLECULAR HEPATOLOGY. 2024-09-24; 2024; 31(1):e103~e104. IF 14 (2023)
Correspondence to letter to the editor on Cho Yu Ri
(Targeted Therapy Branch)

Cho Yu Ri
(Targeted Therapy Branch)
. Correspondence to letter to the editor on "Bariatric intervention improves metabolic dysfunction-associated steatohepatitis in patients with obesity: A systematic review and meta-analysis". CLINICAL AND MOLECULAR HEPATOLOGY. 2024-09-24; 2024; 31:103~104. IF 14 (2023)
SON is an essential RNA splicing factor promoting ErbB2 and ErbB3 expression in breast cancer Kim Jung Hyun
(Cancer Metastasis Branch)

Park Seong Sik
(Cancer Metastasis Branch)
. SON is an essential RNA splicing factor promoting ErbB2 and ErbB3 expression in breast cancer. BRITISH JOURNAL OF CANCER. 2024-09-23; 2024; 131:1437~1449. IF 6.4 (2023)
Proteogenomic characterization identifies clinical subgroups in EGFR and ALK wild-type never-smoker lung adenocarcinoma Han Ji-Youn
(Anticancer Resistance Branch )

KimHyonDeog
(Department of Cancer Biomedical Science)
. Proteogenomic characterization identifies clinical subgroups in EGFR and ALK wild-type never-smoker lung adenocarcinoma. EXPERIMENTAL AND MOLECULAR MEDICINE. 2024-09-19; 2024; 56:2082~2095. IF 9.5 (2023)
Metabolic Dysfunction-Associated Steatotic Liver Disease Is Associated with Increased Risk of Kidney Cancer: A Nationwide Study Chung Jinsoo
(Immuno-oncology Branch)


()
. Metabolic Dysfunction-Associated Steatotic Liver Disease Is Associated with Increased Risk of Kidney Cancer: A Nationwide Study. CANCERS. 2024-09-15; 2024; 16(18):3161~. IF 4.5 (2023)
A Nomogram Using Imaging Features to Predict Ipsilateral Breast Tumor Recurrence After Breast-Conserving Surgery for Ductal Carcinoma In Situ
()

Choi Bo Hwa
(Department of Radiology)
. A Nomogram Using Imaging Features to Predict Ipsilateral Breast Tumor Recurrence After Breast-Conserving Surgery for Ductal Carcinoma In Situ. KOREAN JOURNAL OF RADIOLOGY. 2024-09-12; 2024; 25(10):876~886. IF 4.4 (2023)
First page Prev paging 11 12 13 14 15 16 17 18 19 20 next paging last page